Gilead Sciences (GILD) is due to report earnings Tuesday. Let's review the charts that are looking a little "soft" right now.


Gilead Sciences (GILD) is due to report earnings Tuesday. Let's review the charts that are looking a little "soft" right now.
There is no way to know how long this theme of strong small-cap speculation and short squeezes will continue, but I have no interest in fighting it.
Let's see what we might glean from the charts.
Here's what aggressive traders should look for.
Here's why you should wait for a dip -- not the vaccine glut -- to start buying.
Here's what we found in the latest GME charts.
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login